This issue of the Bankruptcy Update focuses on the recent biotech industry bankruptcy cases of Zymergen and Humanigen.

‘Zymergen’ (Bankr. D. Del. Case No. 23-11661)

On Oct. 3, 2023, Zymergen Inc. and three affiliates filed petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.